Streetbeat News

Analyst Ratings

PFE

In the last quarter, 19 analysts have provided ratings for Pfizer (NYSE:PFE), with a majority being bullish or somewhat bullish. The company has an average 12-month price target of $49.74, with a high of $75.00 and a low of $33.00. This average price target has increased by 14.24% over the past month.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 6:00 pm

BILL

UBS analyst Taylor McGinnis has assumed BILL Holdings (NYSE:BILL) with a Buy rating and set a price target of $126.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 6:00 pm

FLT

Fleetcor Technologies (NYSE:FLT) has received a mix of bullish and indifferent ratings from 13 analysts over the past quarter. The average price target is $293.54, indicating an upside from the current price of $241.68. The average price target has increased by 7.49% over the past month.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 6:00 pm

OVV

Over the past 3 months, 11 analysts have published their opinion on Ovintiv (NYSE:OVV) stock. The average price target is $54.55, implying an upside from the current price of $50.69. The average price target has increased by 7.53% over the past month.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 6:00 pm

FLT

UBS analyst Timothy Chiodo assumes Fleetcor Technologies (NYSE:FLT) with a Neutral rating and announces a price target of $280.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:58 pm

HAS

DA Davidson analyst Linda Bolton Weiser maintains a 'Buy' rating on Hasbro (NASDAQ:HAS) but lowers the price target from $80 to $71.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:56 pm

SEDG

SolarEdge Technologies (NASDAQ:SEDG) shares dropped significantly after the company reduced its Q3 revenue outlook to $720 million-$730 million, down from $880 million-$920 million, and below the consensus of $909.02 million. Analysts from Goldman Sachs, Scotia Bank, and Piper Sandler have downgraded their ratings and lowered their price targets for SEDG due to concerns about European demand and margin challenges. The company's earnings call is scheduled for November 1, 2023.

Portfolio Pulse from Nabaparna Bhattacharya

October 20, 2023 | 5:55 pm

ARDS

HC Wainwright & Co. analyst Vernon Bernardino maintains a 'Buy' rating on Aridis Pharmaceuticals (OTC:ARDS) but has lowered the price target from $10 to $2.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:54 pm

GPN

UBS analyst Timothy Chiodo has assumed Global Payments (NYSE:GPN) with a Neutral rating and set a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:53 pm

FIS

UBS analyst Timothy Chiodo has assumed Fidelity National Info (NYSE:FIS) with a Neutral rating and set a price target of $58.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:51 pm